Litcius/Paper detail

VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells

Chandrani Sarkar, Debanjan Chakroborty, Sandeep Goswami, Hao Fan, Xiaokui Mo, Sujit Basu

2022Journal of Cell Science19 citationsDOIOpen Access PDF

Abstract

We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial growth factor-A (VEGF-A, also known as vascular permeability factor). Interestingly, unlike tumor endothelial cells, normal endothelial cells exhibit very low to no expression of dopamine D2 receptors. Here, for the first time, we demonstrate that through paracrine signaling, VEGF-A can control the expression of dopamine D2 receptors on endothelial cells via Krüppel-like factor 11 (KLF11)-extracellular signal-regulated kinase (ERK) 1/2 pathway. These results thus reveal a novel bidirectional communication between VEGF-A and DAD2 receptors.

Topics & Concepts

BiologyVascular endothelial growth factor CVascular endothelial growth factor BVascular endothelial growth inhibitorCell biologyVascular endothelial growth factor AVascular endothelial growth factorReceptorDopamine receptor D2Dopamine receptorS1PR1Paracrine signallingDopamineAngiogenesisKinase insert domain receptorMAPK/ERK pathwaySignal transductionEndocrinologyCancer researchVEGF receptorsBiochemistryKruppel-like factors researchHippo pathway signaling and YAP/TAZAngiogenesis and VEGF in Cancer